Bio-Techne (TECH) Short-term Investments (2010 - 2025)
Bio-Techne's quarterly Short-term Investments came in at $2.8 million in Q2 2025, down 71.03% year-on-year from $9.8 million in Q2 2024, and down 11.9% quarter-over-quarter from $3.2 million in Q4 2024.
Bio-Techne has reported Short-term Investments for 16 years, with the latest figure at $2.8 million in Q2 2025.
- For the quarter ending Q2 2025, Short-term Investments fell 71.03% year-over-year to $2.8 million; the trailing twelve-month figure through Jun 2025 stood at $2.8 million (down 71.03% YoY), and the FY2025 full-year result was $2.8 million, down 71.03% from the prior year.
- Short-term Investments for Q2 2025 stood at $2.8 million, down from $3.2 million in the prior quarter.
- The five-year high for Short-term Investments was $90.1 million in Q1 2021, with the low at $2.8 million in Q2 2025.
- Average Short-term Investments over 5 years is $31.8 million, with a median of $29.9 million recorded in 2023.
- Year-over-year, Short-term Investments soared 129.37% in 2022 and tumbled 82.79% in 2023.
- Tracing TECH's Short-term Investments over 5 years: stood at $67.1 million in 2021, then plunged by 52.22% to $32.1 million in 2022, then plunged by 82.79% to $5.5 million in 2023, then slumped by 41.54% to $3.2 million in 2024, then declined by 11.9% to $2.8 million in 2025.
- The last three Short-term Investments figures came in at $2.8 million (Q2 2025), $3.2 million (Q4 2024), and $6.7 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.84 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Sep 30, 2024 | 6.67 Mn |
| Jun 30, 2024 | 9.81 Mn |
| Mar 31, 2024 | 5.40 Mn |
| Dec 31, 2023 | 5.52 Mn |
| Sep 30, 2023 | 17.49 Mn |
| Jun 30, 2023 | 16.86 Mn |
| Mar 31, 2023 | 29.92 Mn |
| Dec 31, 2022 | 32.07 Mn |
| Sep 30, 2022 | 37.82 Mn |
| Jun 30, 2022 | 74.46 Mn |
| Mar 31, 2022 | 70.35 Mn |
| Dec 31, 2021 | 67.14 Mn |
| Sep 30, 2021 | 38.74 Mn |
| Jun 30, 2021 | 32.46 Mn |
| Mar 31, 2021 | 90.11 Mn |
| Dec 31, 2020 | 117.43 Mn |
| Sep 30, 2020 | 117.99 Mn |
| Jun 30, 2020 | 124.27 Mn |
| Mar 31, 2020 | 104.87 Mn |
| Dec 31, 2019 | 133.66 Mn |
| Sep 30, 2019 | 58.52 Mn |
| Jun 30, 2019 | 65.15 Mn |
| Mar 31, 2019 | 83.23 Mn |
| Dec 31, 2018 | 70.65 Mn |
| Sep 30, 2018 | 69.05 Mn |
| Jun 30, 2018 | 59.76 Mn |
| Mar 31, 2018 | 89.83 Mn |
| Dec 31, 2017 | 40.93 Mn |
| Sep 30, 2017 | 50.26 Mn |
| Jun 30, 2017 | 66.10 Mn |
| Mar 31, 2017 | 53.78 Mn |
| Dec 31, 2016 | 40.00 Mn |
| Sep 30, 2016 | 52.38 Mn |
| Jun 30, 2016 | 31.60 Mn |
| Mar 31, 2016 | 18.87 Mn |
| Dec 31, 2015 | 51.47 Mn |
| Sep 30, 2015 | 38.42 Mn |
| Jun 30, 2015 | 56.39 Mn |
| Mar 31, 2015 | 53.50 Mn |
| Dec 31, 2014 | 46.97 Mn |
| Sep 30, 2014 | 32.57 Mn |
| Jun 30, 2014 | 44.79 Mn |
| Mar 31, 2014 | 96.53 Mn |
| Dec 31, 2013 | 88.45 Mn |
| Sep 30, 2013 | 100.84 Mn |
| Jun 30, 2013 | 169.15 Mn |
| Mar 31, 2013 | 162.16 Mn |
| Dec 31, 2012 | 142.81 Mn |
| Sep 30, 2012 | 142.26 Mn |
| Jun 30, 2012 | 152.31 Mn |
| Mar 31, 2012 | 124.33 Mn |
| Dec 31, 2011 | 56.76 Mn |
| Sep 30, 2011 | 54.12 Mn |
| Jun 30, 2011 | 63.20 Mn |
| Mar 31, 2011 | 55.27 Mn |
| Dec 31, 2010 | 58.99 Mn |
| Sep 30, 2010 | 57.62 Mn |
| Jun 30, 2010 | 44.67 Mn |